Daniela Fischer, Ph.D.

Associate Director Regulatory Affairs CMC at Novartis Pharmaceutical Manufacturing

Speaker

Daniela Fischer has worked in the pharmaceutical industry for over 15 years, mainly in analytical development and Regulatory CMC. She began her career at Carbogen Amcis AG and then worked at Bruker Biospin AG and Sandoz GmbH in analytical development before moving to Regulatory CMC at Sandoz GmbH and later Novartis, where she covered small molecules (generics), biosimilars and since 2021 synthetic oligonucleotides. She holds a Ph.D. in organic chemistry from the University of Regensburg, Germany.